Yu, S., Yan, C., Yang, X., He, S., Liu, J., Qin, C., . . . Jia, L. (2016). Pharmacoproteomic analysis reveals that metapristone (RU486 metabolite) intervenes E-cadherin and vimentin to realize cancer metastasis chemoprevention. Sci Rep.
Citação norma ChicagoYu, Suhong, et al. "Pharmacoproteomic Analysis Reveals That Metapristone (RU486 Metabolite) Intervenes E-cadherin and Vimentin to Realize Cancer Metastasis Chemoprevention." Sci Rep 2016.
MLA citiranjeYu, Suhong, et al. "Pharmacoproteomic Analysis Reveals That Metapristone (RU486 Metabolite) Intervenes E-cadherin and Vimentin to Realize Cancer Metastasis Chemoprevention." Sci Rep 2016.
Opozorilo: Ti citati niso vedno 100% točni.